Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02756624 · ClinicalTrials.gov registry record · Phase 3
A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution
A Phase 3 study, sponsored by Nicox Ophthalmics.
- Completed
- Registry status
- Phase 3
- Development phase
- 516
- Enrollment target
NCT02756624: Completed Phase 3 study, sponsored by Nicox Ophthalmics.
NCT02756624 is a Phase 3 study that has completed, run by Nicox Ophthalmics. The registered enrollment target is 516 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02756624, a Phase 3 study, has completed, sponsored by Nicox Ophthalmics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 516 participants
- Enrollment target
Study Summary
This is study is evaluating the safety and tolerability of AC-170 Ophthalmic Solution
Primary Outcome
Tolerability was assessed upon instillation of study medication, at 1 minute and 2 minutes post study medication instillation. Drop comfort was assessed using a 0-to 10 scale where 0=very comfortable and 10=very uncomfortable.
Interventions
- DRUG AC-170 0.24%
- DRUG AC-170 Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 516 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-08 |
| Phase | Phase 3 |
What the finished NCT02756624 record still lists
NCT02756624 is an interventional study that assigns participants to a tested intervention. The registered 516 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% lower).
The record links to 0 conditions, and to 2 interventions - of which AC-170 0.24% is the first listed.
NCT02756624 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02756624 about?
NCT02756624 is a clinical study titled "A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution". This is study is evaluating the safety and tolerability of AC-170 Ophthalmic Solution
What is the current status of trial NCT02756624?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 516 participants. The study started on 2016-04. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02756624?
The interventions under investigation include: AC-170 0.24% (DRUG), AC-170 Vehicle (DRUG).
Who is sponsoring clinical trial NCT02756624?
This trial is sponsored by Nicox Ophthalmics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02756624's enrollment target sits among peer trials
516 724th of 2000 higher than 1,277 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05933083 · 516 participants · NA
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- NCT05676450 · 517 participants · NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- NCT06804837 · 515 participants · NA
Implement and Test Visual Consent Template and Process
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia